This retrospective study involving patients with acute stroke requiring transfers from hospitals in the Get With the Guidelines–Stroke registry assesses patient
Ginkgo diterpene lactone meglumine was found to be safe and efficacious among patients with acute ischemic stroke when treated within 48 hours of symptom onset.